Skip to content

Clinical trials

Acute Coronary Syndrome trials in Bulgaria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acute Coronary Syndrome Country / region: Bulgaria Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20083
20094
20103
20142
20152
20161
20171
20181
20201
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
GlaxoSmithKline3
Bristol-Myers Squibb2
Janssen Research & Development, LLC2
Sanofi2
Takeda2
Bulgarian Cardiac Institute1
CSL Behring1
Cogentus Pharmaceuticals1
DalCor Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acute Coronary Syndrome22
Myocardial Infarction10
Angina, Unstable5
Cardiovascular Diseases4
Coronary Artery Disease3
Heart Diseases3
Non-ST Elevated Myocardial Infarction3
Stroke3
Atherosclerosis2
Diabetes Mellitus2

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.